1. Home
  2. FBIN vs DFTX Comparison

FBIN vs DFTX Comparison

Compare FBIN & DFTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

HOLD

Current Price

$39.36

Market Cap

5.5B

ML Signal

HOLD

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

N/A

Current Price

$38.77

Market Cap

5.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FBIN
DFTX
Founded
1988
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.9B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
FBIN
DFTX
Price
$39.36
$38.77
Analyst Decision
Hold
Strong Buy
Analyst Count
11
8
Target Price
$54.60
$38.50
AVG Volume (30 Days)
2.0M
1.8M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
2.58%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$4,463,200,000.00
N/A
Revenue This Year
$2.68
N/A
Revenue Next Year
$3.60
N/A
P/E Ratio
$3,975.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.34
$14.62
52 Week High
$64.84
$49.70

Technical Indicators

Market Signals
Indicator
FBIN
DFTX
Relative Strength Index (RSI) 31.33 44.75
Support Level $37.87 $16.37
Resistance Level $40.26 $49.13
Average True Range (ATR) 1.31 1.88
MACD -0.16 -0.06
Stochastic Oscillator 8.48 29.07

Price Performance

Historical Comparison
FBIN
DFTX

About FBIN Fortune Brands Innovations Inc.

Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

Share on Social Networks: